Roundup’s Risks Could Go Well Beyond Cancer

IRT’s Take:

This article in Bloomberg does a nice job of summarizing the many suspected health dangers of glyphosate (although largely ignores the fact that the complete Roundup formulation has NEVER BEEN TESTED!). Then it poses the question: Why aren’t U.S. regulators looking into this?

Here’s a great take on that issue from our exclusive interview with Brent Wisner, the Monsanto-slaying lead attorney in two of the recent monumental verdicts. Here Brent addresses this issue of why the EPA finds it so hard to reevaluate and reexamine its stance on glyphosate. We totally agree and it’s why we need to keep the pressure on.

This additional short clip addresses that other burning issue for our alert consumers: How did this stuff ever get on the market in the first place?

The article excerpt below was originally published in Bloomberg.

Chemicals giant Bayer AG is reeling after a jury awarded $2 billion in damages to people who say they contracted cancer after years of using Roundup, a popular weedkiller manufactured by Bayer subsidiary Monsanto Co. Bayer probably won’t pay out the full $2 billion. But more than 10,000 further cases are pending, worrying Bayer investors as well as farmers who rely on the product as a cheap, effective herbicide.

Cancer may only be part of the story. Studies over the past decade suggest that glyphosate — the active ingredient in Roundup — pollutes water sources, hangs around in soil far longer than previously suspected, and routinely taints human food supplies. In both the U.S. and Europe, the supposedly safe limits for human ingestion are based on long-outdated science. Research also points to serious adverse consequences for the environment, and there are indications glyphosate can cause disease in mammals even several generations removed from the initial exposure. Continue reading in Bloomberg.

Watch our entire exclusive series of interviews with Brent Wisner here.